Y
Yan-yan Guo
Researcher at Fourth Military Medical University
Publications - 25
Citations - 786
Yan-yan Guo is an academic researcher from Fourth Military Medical University. The author has contributed to research in topics: Anxiolytic & AMPA receptor. The author has an hindex of 13, co-authored 22 publications receiving 636 citations. Previous affiliations of Yan-yan Guo include Xi'an Jiaotong University.
Papers
More filters
Journal ArticleDOI
CB1 agonism prolongs therapeutic window for hormone replacement in ovariectomized mice
Kun Zhang,Qi Yang,Le Yang,Yan-Jiao Li,Xin-shang Wang,Yu-Jiao Li,Rui-li Dang,Shao-yu Guan,Yan-yan Guo,Ting Sun,Yu-Mei Wu,An Liu,Yan Zhang,Shui-bing Liu,Ming-gao Zhao +14 more
TL;DR: It is demonstrated that an HT time window in mice can be prolonged by cotreatment with a CB1 agonist, implying a potential strategy for HT in long-term menopausal women.
Journal ArticleDOI
Increased coupling of caveolin-1 and estrogen receptor α contributes to the fragile X syndrome.
Qi Yang,Le Yang,Kun Zhang,Yan-yan Guo,Shui-bing Liu,Yu-Mei Wu,Xiao-Qiang Li,Qian Song,Min Zhuo,Min Zhuo,Ming-gao Zhao,Ming-gao Zhao +11 more
TL;DR: The hypothesis that impaired ER–caveolae coupling contributes to the mental retardation of FXS is tested.
Journal ArticleDOI
Neuroprotective effects of a novel translocator protein (18 kDa) ligand, ZBD-2, against focal cerebral ischemia and NMDA-induced neurotoxicity
Xu-bo Li,Hong-liang Guo,Tian-yao Shi,Le Yang,Min Wang,Kun Zhang,Yan-yan Guo,Yu-Mei Wu,Shui-bing Liu,Ming-gao Zhao +9 more
TL;DR: In cultured cortical neurons, treatment with ZBD‐2 attenuated excitotoxicity induced by N‐methyl‐d‐aspartate (NMDA) exposure and systemic treatment provided significant neuroprotection in mice subjected to middle cerebral artery occlusion, providing direct evidence that neuroprotection by Z BD‐2 is partially mediated by inhibiting GluN2B‐containing NMDA receptor‐mediated excitOToxicity.
Journal ArticleDOI
Epigenetic suppression of liver X receptor β in anterior cingulate cortex by HDAC5 drives CFA-induced chronic inflammatory pain
Yu-Jiao Li,Kun Zhang,Ting Sun,Jian Wang,Yan-yan Guo,Le Yang,Qi Yang,Yan-Jiao Li,Shui-bing Liu,Ming-gao Zhao,Yu-Mei Wu +10 more
TL;DR: Findings highlight an epigenetic mechanism underlying LXR β deficits linked to CIP, and LXRβ activation may represent a potential novel target for the treatment of CIP with an alteration in inflammation responses and synaptic transmission in ACC.
Journal ArticleDOI
Cannabinoid receptor GPR55 activation blocks nicotine use disorder by regulation of AMPAR phosphorylation.
Qing-Qing Liu,Jiaoyan Yu,Xi Li,Yan-yan Guo,Ting Sun,Li Luo,Jing Ren,Wei Jiang,Ruitao Zhang,Peng Yang,Qi Yang +10 more
TL;DR: In this article, the authors used the conditioned place preference (CPP) paradigm to investigate nicotine use disorder behavior in mice and found that G protein-coupled receptor 55 (GPR55) activation significantly reduced nicotine-CPP behavior by decreasing spontaneous excitatory postsynaptic currents frequency in the nucleus accumbens (NAc) and the release of dopamine in serum.